TLDR Peter Schiff warns that the recent Bitcoin crash is a signal of potential trouble for cryptocurrency investors. Bitcoin’s sharp decline followed worsening trade tensions between the U.S. and China, affecting both stocks and cryptocurrencies. Despite a brief recovery, Bitcoin has struggled to maintain momentum as geopolitical uncertainties persist. Schiff argues that Bitcoin’s price could [...] The post Peter Schiff Claims Bitcoin Crash Was a Warning, Not a Buying Chance appeared first on CoinCentral.TLDR Peter Schiff warns that the recent Bitcoin crash is a signal of potential trouble for cryptocurrency investors. Bitcoin’s sharp decline followed worsening trade tensions between the U.S. and China, affecting both stocks and cryptocurrencies. Despite a brief recovery, Bitcoin has struggled to maintain momentum as geopolitical uncertainties persist. Schiff argues that Bitcoin’s price could [...] The post Peter Schiff Claims Bitcoin Crash Was a Warning, Not a Buying Chance appeared first on CoinCentral.

Peter Schiff Claims Bitcoin Crash Was a Warning, Not a Buying Chance

2025/10/15 01:57
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

TLDR

  • Peter Schiff warns that the recent Bitcoin crash is a signal of potential trouble for cryptocurrency investors.
  • Bitcoin’s sharp decline followed worsening trade tensions between the U.S. and China, affecting both stocks and cryptocurrencies.
  • Despite a brief recovery, Bitcoin has struggled to maintain momentum as geopolitical uncertainties persist.
  • Schiff argues that Bitcoin’s price could drop suddenly, exposing its volatility and challenging its claim as “digital gold.”
  • Gold has reached new highs, further reinforcing Schiff’s view that it remains a safer investment compared to Bitcoin.

Peter Schiff, a prominent financial commentator, has stated that Friday’s Bitcoin crash was not just a buying opportunity. He believes it was a “warning” that signals trouble ahead for crypto investors. Schiff, who has been critical of Bitcoin for years, predicts that crypto buyers will soon face a harsh reality.

Bitcoin Crash Follows U.S.-China Trade Woes

Bitcoin saw a significant decline last Friday, following worsening trade tensions between the U.S. and China. The sharp drop in Bitcoin’s price was accompanied by a steep fall in U.S. equities. The cryptocurrency market also suffered a $19 billion liquidation, which Tom Lee of Fundstrat suggests could be understated.

Despite this, Bitcoin experienced a brief recovery after the White House hinted at a possible trade deal with China. However, the cryptocurrency’s gains were short-lived as concerns over trade tensions resurfaced. Bitcoin’s price dipped to a low of $113,030 earlier today, according to CoinGecko.

Bitcoin’s recovery remains uncertain as it remains susceptible to geopolitical developments. Both Bitcoin and U.S. equities continue to react sharply to news related to trade relations between the two superpowers. As the situation develops, traders and investors are watching closely for signs of further price volatility.

Gold Surges While Bitcoin Struggles, Says Schiff

Meanwhile, gold reached a new peak, surpassing the $4,100 level, signaling a growing preference for the precious metal. Schiff has long argued that gold remains the superior store of value. He views the surge in gold’s price as a rebuttal to Bitcoin’s claim to be “digital gold.”

Schiff warns that Bitcoin’s price could plummet at any moment, exposing its instability.

Bitcoin’s performance this year has been lackluster, with little to suggest it will outperform other assets. Schiff remains confident that gold will continue to rise, while cryptocurrencies face ongoing challenges. Investors may face costly lessons as the market continues to fluctuate.

The post Peter Schiff Claims Bitcoin Crash Was a Warning, Not a Buying Chance appeared first on CoinCentral.

Market Opportunity
Notcoin Logo
Notcoin Price(NOT)
$0,0003702
$0,0003702$0,0003702
+2,80%
USD
Notcoin (NOT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09